# Gabapentin for Sleep in Critically Ill Patients

> **NCT04631510** · EARLY_PHASE1 · COMPLETED · sponsor: **Tufts Medical Center** · enrollment: 80 (actual)

## Conditions studied

- Intensive Care Unit Sleep Disruption

## Interventions

- **DRUG:** Gabapentin 300 mg PO at 8 PM

## Key facts

- **NCT ID:** NCT04631510
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2023-08-04
- **Final completion:** 2025-05-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04631510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04631510, "Gabapentin for Sleep in Critically Ill Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04631510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*